LBA19 Capivasertib (C) + paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trial
| Autor: | Schmid, P., McArthur, H.L., Cortés, J., Xu, B., Cardoso, F., Casalnuovo, M.L., Demirci, U., Freitas, R., Jr, Ghosh, J., Hegg, R., Iwata, H., Lopez Chuken, Y.A., Nechaeva, M., Robson, M.E., Villalobos Valencia, R., Lloyd, A., D'Cruz, C., Foxley, A., Park, Y.H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1212-S1213 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|